We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Centene
CNC
$31.3B
| $3.09M | ﹤0.01% |
109,236
-5,490
| -5% | -$162K |
|
602
Smart Sand
SND
$200M
| $3.09M | ﹤0.01% |
+186,460
| New | +$2.48M |
|
603
Costamare
CMRE
$1.9B
| $3.08M | ﹤0.01% |
550,705
+330,532
| +150% | +$2.19M |
|
|
MIK
604
DELISTED
Michaels Stores, Inc
MIK
| $3.07M | ﹤0.01% |
+150,253
| New | +$3.49M |
|
|
NWLI
605
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $3.04M | ﹤0.01% |
9,777
| – | – |
|
606
Williams-Sonoma
WSM
$26.7B
| $3.03M | ﹤0.01% |
+125,234
| New | +$3.19M |
|
|
CBR
607
DELISTED
CIBER Inc.
CBR
| $3.03M | ﹤0.01% |
4,795,779
-876,187
| -15% | -$754K |
|
|
EXPR
608
DELISTED
Express, Inc.
EXPR
| $3M | ﹤0.01% |
13,958
-701
| -5% | -$172K |
|
|
FLIC
609
DELISTED
First of Long Island Corp
FLIC
| $3M | ﹤0.01% |
105,201
-26,289
| -20% | -$649K |
|
610
Cameco
CCJ
$38.3B
| $3M | ﹤0.01% |
286,642
+78,303
| +38% | +$707K |
|
|
GMLP
611
DELISTED
Golar LNG Partners LP
GMLP
| $3M | ﹤0.01% |
124,790
| – | – |
|
|
LXFT
612
DELISTED
Luxoft Holding, Inc.
LXFT
| $3M | ﹤0.01% |
+53,389
| New | +$2.85M |
|
613
Graham Corp
GHM
$1.22B
| $2.93M | ﹤0.01% |
132,080
| – | – |
|
|
OPB
614
DELISTED
Opus Bank Common Stock
OPB
| $2.92M | ﹤0.01% |
+97,288
| New | +$2.6M |
|
|
NXRT
615
NexPoint Residential Trust
NXRT
$665M
| $2.92M | ﹤0.01% |
130,600
-42,860
| -25% | -$842K |
|
616
Grupo Aeroportuario del Sureste
ASR
$8.03B
| $2.88M | ﹤0.01% |
20,000
| – | – |
|
|
LGF.B
617
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.88M | ﹤0.01% |
+117,240
| New | +$2.99M |
|
618
VF Corp
VFC
$6.68B
| $2.87M | ﹤0.01% |
+57,088
| New | +$2.96M |
|
|
STFC
619
DELISTED
State Auto Financial Corp
STFC
| $2.86M | ﹤0.01% |
106,843
+1,935
| +2% | +$47.8K |
|
620
Compass Minerals
CMP
$1.24B
| $2.85M | ﹤0.01% |
36,375
| – | – |
|
621
Carriage Services
CSV
$618M
| $2.85M | ﹤0.01% |
99,328
| – | – |
|
|
KATE
622
DELISTED
Kate Spade & Company
KATE
| $2.84M | ﹤0.01% |
151,900
-2,000
| -1% | -$32.8K |
|
623
Pediatrix Medical
MD
$2.16B
| $2.83M | ﹤0.01% |
42,384
| – | – |
|
624
UFP Technologies
UFPT
$1.84B
| $2.81M | ﹤0.01% |
110,527
-40,179
| -27% | -$1.04M |
|
|
TA
625
DELISTED
TravelCenters of America LLC
TA
| $2.8M | ﹤0.01% |
78,800
+2,124
| +3% | +$71.9K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.